BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32067651)

  • 21. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left atrial appendage occlusion with Watchman device after incomplete surgical ligation.
    Manongi N; Volodarskiy A; Goldbarg S
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36379620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally Invasive Closure of the Left Atrial Appendage: A Non-Pharmacologic Approach to Prevention of Stroke in Patients with Atrial Fibrillation.
    McCauley BD; Chu AF
    R I Med J (2013); 2017 May; 100(5):23-26. PubMed ID: 28459917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage.
    Fahmy P; Spencer R; Tsang M; Gooderham P; Saw J
    Can J Cardiol; 2016 Mar; 32(3):349-54. PubMed ID: 26831513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.
    Saw J; Fahmy P; DeJong P; Lempereur M; Spencer R; Tsang M; Gin K; Jue J; Mayo J; McLaughlin P; Nicolaou S
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1198-206. PubMed ID: 25851318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
    Gangireddy SR; Halperin JL; Fuster V; Reddy VY
    Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenecity and thrombogenicity of the residual left atrial appendage stump following surgical exclusion of the appendage in patients with atrial fibrillation.
    Mohanty S; Di Biase L; Trivedi C; Choudhury F; Della Rocca DG; Romero J; Gianni C; Sanchez J; Hranitzky P; Gallinghouse GJ; Al-Ahmad A; Horton RP; Burkhardt D; Natale A
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):339-347. PubMed ID: 30575181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization.
    Aryana A; Singh SK; Singh SM; O'Neill PG; Bowers MR; Allen SL; Lewandowski SL; Vierra EC; d'Avila A
    Heart Rhythm; 2015 Jul; 12(7):1431-7. PubMed ID: 25998141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left atrial appendage exclusion for prevention of stroke in atrial fibrillation: review of minimally invasive approaches.
    Moss JD
    Curr Cardiol Rep; 2014 Feb; 16(2):448. PubMed ID: 24408675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study).
    Parikh V; Rasekh A; Mohanty S; Yarlagadda B; Atkins D; Bommana S; Turagam M; Jeffery C; Carroll H; Nydegger C; Jaeger M; Dar T; Cheng J; Gopinnathanair R; Dibiase L; Lee R; Horton R; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2020 Apr; 57(3):409-416. PubMed ID: 31863251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence.
    Noelck N; Papak J; Freeman M; Paynter R; Low A; Motu'apuaka M; Kondo K; Kansagara D
    Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):395-405. PubMed ID: 27407055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.